Literature DB >> 8356729

Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients.

M B Regazzi1, I Iacona, C Campana, V Raddato, C Lesi, G Perani, A Gavazzi, M Viganò.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8356729

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  28 in total

Review 1.  Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant?

Authors:  Jennifer Martin; Henry Krum
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions.

Authors:  John D Clarke; Nathan J Cherrington
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-01-27       Impact factor: 4.481

3.  Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.

Authors:  Mia Hedman; Marjatta Antikainen; Christer Holmberg; Mikko Neuvonen; Michel Eichelbaum; Kari T Kivistö; Pertti J Neuvonen; Mikko Niemi
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

Review 4.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

5.  Successful strategy to improve the specificity of electronic statin-drug interaction alerts.

Authors:  Hanna Marita Seidling; Caroline Henrike Storch; Thilo Bertsche; Christian Senger; Jens Kaltschmidt; Ingeborg Walter-Sack; Walter Emil Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2009-07-30       Impact factor: 2.953

6.  Combination of pravastatin and cyclosporin in transplant patients.

Authors:  U Christians
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.

Authors:  J P Desager; Y Horsmans
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

Review 8.  Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Authors:  Pertti J Neuvonen; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 9.  Pravastatin: a review of its use in elderly patients.

Authors:  Lynne M Bang; Karen L Goa
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Pharmacokinetics of a three-way drug interaction between danoprevir, ritonavir and the organic anion transporting polypeptide (OATP) inhibitor ciclosporin.

Authors:  Barbara J Brennan; Sebastian A Moreira; Peter N Morcos; Mercidita T Navarro; Jiney Asthappan; Petra Goelzer; Paul Weigl; Patrick F Smith
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.